Michael A. Jobst, MD
CLEVELAND—One-year follow-up of colon cancer patients undergoing right or left colectomy with a novel miniaturized robotic-assisted surgery device has found that the device demonstrates technical prowess and a safe surgical profile.
The study revealed no evidence of disease recurrence in any patient who underwent curative resection.
“We utilized the first-ever in-human trial of a miniaturized robotic-assisted surgery system, results of which